Rajesh Gupta1, Dylan D Fortman2, Daniel R Morgenstern2, Christopher J Cooper2. 1. Department of Medicine, Division of Cardiovascular Medicine, University of Toledo Medical Center, 3000 Arlington Ave, MS# 1118, Toledo, OH, 43614, USA. rajesh.gupta@utoledo.edu. 2. College of Medicine and Life Sciences, University of Toledo, Toledo, OH, 43614, USA.
Abstract
PURPOSE OF REVIEW: Acute pulmonary embolism is a major cause of morbidity and mortality in the USA and throughout the world. This review will summarize recent developments in short- and long-term mortality risk assessment after an acute pulmonary embolism. RECENT FINDINGS: Recent guidelines have emphasized risk stratification of acute PE patients on the basis of blood pressure, right ventricular size, and biomarker status. Ongoing work is testing various acute treatment strategies for improvement of symptom burden, length of stay, quality of life, and possibly mortality risk reduction. Long-term outcomes among subjects with acute PE are less well studied. Long-term mortality largely correlates with baseline co-morbidity burden, although there may be an association between acute PE severity and long-term outcomes. Acute PE risk stratification and treatment, as well as long-term follow-up of patients with acute PE, are rapidly developing areas and many promising innovations are underway.
PURPOSE OF REVIEW: Acute pulmonary embolism is a major cause of morbidity and mortality in the USA and throughout the world. This review will summarize recent developments in short- and long-term mortality risk assessment after an acute pulmonary embolism. RECENT FINDINGS: Recent guidelines have emphasized risk stratification of acute PE patients on the basis of blood pressure, right ventricular size, and biomarker status. Ongoing work is testing various acute treatment strategies for improvement of symptom burden, length of stay, quality of life, and possibly mortality risk reduction. Long-term outcomes among subjects with acute PE are less well studied. Long-term mortality largely correlates with baseline co-morbidity burden, although there may be an association between acute PE severity and long-term outcomes. Acute PE risk stratification and treatment, as well as long-term follow-up of patients with acute PE, are rapidly developing areas and many promising innovations are underway.
Authors: D Spirk; D Aujesky; M Husmann; D Hayoz; T Baldi; B Frauchiger; M Banyai; I Baumgartner; N Kucher Journal: Thromb Haemost Date: 2011-08-11 Impact factor: 5.249
Authors: Gregory Piazza; Benjamin Hohlfelder; Michael R Jaff; Kenneth Ouriel; Tod C Engelhardt; Keith M Sterling; Noah J Jones; John C Gurley; Rohit Bhatheja; Robert J Kennedy; Nilesh Goswami; Kannan Natarajan; John Rundback; Immad R Sadiq; Stephen K Liu; Narinder Bhalla; M Laiq Raja; Barry S Weinstock; Jacob Cynamon; Fakhir F Elmasri; Mark J Garcia; Mark Kumar; Juan Ayerdi; Peter Soukas; William Kuo; Ping-Yu Liu; Samuel Z Goldhaber Journal: JACC Cardiovasc Interv Date: 2015-08-24 Impact factor: 11.195
Authors: John A Heit; Aneel Ashrani; Daniel J Crusan; Robert D McBane; Tanya M Petterson; Kent R Bailey Journal: Thromb Haemost Date: 2016-12-15 Impact factor: 5.249
Authors: Robert C Neely; John G Byrne; Igor Gosev; Lawrence H Cohn; Quratulain Javed; James D Rawn; Samuel Z Goldhaber; Gregory Piazza; Sary F Aranki; Prem S Shekar; Marzia Leacche Journal: Ann Thorac Surg Date: 2015-07-10 Impact factor: 4.330
Authors: Drahomir Aujesky; D Scott Obrosky; Roslyn A Stone; Thomas E Auble; Arnaud Perrier; Jacques Cornuz; Pierre-Marie Roy; Michael J Fine Journal: Am J Respir Crit Care Med Date: 2005-07-14 Impact factor: 21.405